人树突状细胞亚群在抗肿瘤免疫中的作用
The Role of Human Dendritic Cell Subsets in Antitumor Immunity
DOI: 10.12677/ACM.2020.103037, PDF,   
作者: 马莉莉, 程春来：长江航运总医院肿瘤科，湖北 武汉；谷飞飞：华中科技大学同济医学院附属协和医院肿瘤中心，湖北 武汉
关键词: 树突状细胞；抗肿瘤免疫；免疫应答；抗原递呈细胞；肿瘤；Dendritic Cell； Antitumor Immunity； Immune Responses； Antigen Presenting Cells； Tumor
摘要: 树突状细胞是人体功能最强大的抗原递呈细胞，在诱导和调控机体针对病原体、自身抗原和癌症的免疫应答中发挥关键作用。树突状细胞是一群异质性细胞，不同的亚群具有独特的表型和功能。基于单核细胞来源的树突状细胞的治疗性疫苗在恶性肿瘤的治疗中显示出一定的疗效，其他树突状细胞亚群在抗肿瘤免疫中也发挥着重要作用。目前，还没有文献对不同树突状细胞亚群在抗肿瘤免疫中的作用进行系统性地阐述。为此，我们对人树突状细胞亚群的生物学特征及其在抗肿瘤免疫中的作用进行综述。
Abstract: Dendritic cells (DCs) are the most potent antigen presenting cells (APC) and critical regulators of immune responses. They play a key role in initiating and regulating the immune responses to pathogens, self-antigens, and cancers. DCs are heterogeneous and highly specialized antigen-presenting cells. Monocyte-derived DCs (MoDC) based therapeutic vaccines have been applied in the treatment of malignancies and showed certain efficacy. And the other dendritic cell subsets also play an important role in antitumor immunity. However, there is no literature that summarizes the roles of different dendritic cell subsets in antitumor immunity until now. Therefore, we reviewed the biological characteristics of human dendritic cell subsets and their roles in antitumor immunity.
文章引用：马莉莉, 程春来, 谷飞飞. 人树突状细胞亚群在抗肿瘤免疫中的作用[J]. 临床医学进展, 2020, 10(3): 232-238. https://doi.org/10.12677/ACM.2020.103037

参考文献

[1] Rosenberg, S.A. (1999) A New Era for Cancer Immunotherapy Based on the Genes That Encode Cancer Antigens. Immunity, 10, 281-287. [Google Scholar] [CrossRef] 
[2] Coley, W.B. (1891) II. Contribution to the Knowledge of Sarcoma. Annals of Surgery, 14, 199-220. [Google Scholar] [CrossRef] [PubMed]
[3] Couzin-Frankel, J. (2013) Breakthrough of the Year 2013. Cancer Immunotherapy. Science, 342, 1432-1433. [Google Scholar] [CrossRef] [PubMed]
[4] Steinman, R.M. and Cohn, Z.A. (1973) Identification of a Novel Cell Type in Peripheral Lymphoid Organs of Mice. I. Morphology, Quantitation, Tissue Distribution. Journal of Experimental Medicine, 137, 1142-1162. [Google Scholar] [CrossRef] [PubMed]
[5] Collin, M., McGovern, N. and Haniffa, M. (2013) Human Dendritic Cell Subsets. Immunology, 140, 22-30. [Google Scholar] [CrossRef] [PubMed]
[6] Banchereau, J. and Steinman, R.M. (1998) Dendritic Cells and the Control of Immunity. Nature, 392, 245-252. [Google Scholar] [CrossRef] [PubMed]
[7] Steinman, R.M. and Banchereau, J. (2007) Taking Dendritic Cells into Medicine. Nature, 449, 419-426. [Google Scholar] [CrossRef] [PubMed]
[8] Steinman, R.M. (2012) Decisions about Dendritic Cells: Past, Present, and Future. Annual Review of Immunology, 30, 1-22. [Google Scholar] [CrossRef] [PubMed]
[9] Jego, G., Pascual, V., Palucka, A.K. and Banchereau, J. (2005) Dendritic Cells Control B Cell Growth and Differentiation. Current Directions in Autoimmunity, 8, 124-139. [Google Scholar] [CrossRef] [PubMed]
[10] Qi, H., Egen, J.G., Huang, A.Y. and Germain, R.N. (2006) Extrafollicular Activation of Lymph Node B Cells by Antigen-Bearing Dendritic Cells. Science, 312, 1672-1676. [Google Scholar] [CrossRef] [PubMed]
[11] Batista, F.D. and Harwood, N.E. (2009) The Who, How and Where of Antigen Presentation to B Cells. Nature Reviews Immunology, 9, 15-27. [Google Scholar] [CrossRef] [PubMed]
[12] Bergtold, A., Desai, D.D., Gavhane, A. and Clynes, R. (2005) Cell Surface Recycling of Internalized Antigen Permits Dendritic Cell Priming of B Cells. Immunity, 23, 503-514. [Google Scholar] [CrossRef] [PubMed]
[13] Palucka, K. and Banchereau, J. (2012) Cancer Immunotherapy via Dendritic Cells. Nature Reviews Cancer, 12, 265-277. [Google Scholar] [CrossRef] [PubMed]
[14] Wilson, N.S., El-Sukkari, D., Belz, G.T., Smith, C.M., Steptoe, R.J., et al. (2003) Most Lymphoid Organ Dendritic Cell Types Are Phenotypically and Functionally Immature. Blood, 102, 2187-2194. [Google Scholar] [CrossRef] [PubMed]
[15] Trombetta, E.S. and Mellman, I. (2005) Cell Biology of Antigen Processing in Vitro and in Vivo. Annual Review of Immunology, 23, 975-1028. [Google Scholar] [CrossRef] [PubMed]
[16] Heath, W.R. and Carbone, F.R. (2001) Cross-Presentation, Dendritic Cells, Tolerance and Immunity. Annual Review of Immunology, 19, 47-64. [Google Scholar] [CrossRef] [PubMed]
[17] Liu, Y.J., Soumelis, V., Watanabe, N., Ito, T., Wang, Y.H., et al. (2007) TSLP: An Epithelial Cell Cytokine That Regulates T Cell Differentiation by Conditioning Dendritic Cell Maturation. Annual Review of Immunology, 25, 193-219. [Google Scholar] [CrossRef] [PubMed]
[18] Melero, I., Gaudernack, G., Gerritsen, W., Huber, C., Parmiani, G., et al. (2014) Therapeutic Vaccines for Cancer: An Overview of Clinical Trials. Nature Reviews Clinical Oncology, 11, 509-524. [Google Scholar] [CrossRef] [PubMed]
[19] Kantoff, P.W., Higano, C.S., Shore, N.D., Berger, E.R., Small, E.J., et al. (2010) Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer. The New England Journal of Medicine, 363, 411-422. [Google Scholar] [CrossRef] 
[20] Anguille, S., Smits, E.L., Bryant, C., Van Acker, H.H., Goossens, H., et al. (2015) Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy. Pharmacological Reviews, 67, 731-753. [Google Scholar] [CrossRef] [PubMed]
[21] Anguille, S., Smits, E.L., Lion, E., van Tendeloo, V.F. and Berneman, Z.N. (2014) Clinical Use of Dendritic Cells for Cancer Therapy. The Lancet Oncology, 15, e257-e267. [Google Scholar] [CrossRef] 
[22] Chiang, C.L., Balint, K., Coukos, G. and Kandalaft, L.E. (2015) Potential Approaches for More Successful Dendritic Cell-Based Immunotherapy. Expert Opinion on Biological Therapy, 15, 569-582. [Google Scholar] [CrossRef] [PubMed]
[23] Mohamadzadeh, M., Berard, F., Essert, G., Chalouni, C., Pulendran, B., et al. (2001) Interleukin 15 Skews Monocyte Differentiation into Dendritic Cells with Features of Langer-hans Cells. Journal of Experimental Medicine, 194, 1013-1020. [Google Scholar] [CrossRef] [PubMed]
[24] Dubsky, P., Saito, H., Leogier, M., Dantin, C., Connolly, J.E., et al. (2007) IL-15-Induced Human DC Efficiently Prime Melanoma-Specific Naive CD8+ T Cells to Differentiate into CTL. European Journal of Immunology, 37, 1678-1690. [Google Scholar] [CrossRef] [PubMed]
[25] Jongbloed, S.L., Kassianos, A.J., McDonald, K.J., Clark, G.J., Ju, X., et al. (2010) Human CD141+ (BDCA-3)+ Dendritic Cells (DCs) Represent a Unique Myeloid DC Subset That Cross-Presents Necrotic Cell Antigens. Journal of Experimental Medicine, 207, 1247-1260. [Google Scholar] [CrossRef] [PubMed]
[26] Ueno, H., Klechevsky, E., Schmitt, N., Ni, L., Flamar, A.L., et al. (2011) Targeting Human Dendritic Cell Subsets for Improved Vaccines. Seminars in Immunology, 23, 21-27. [Google Scholar] [CrossRef] [PubMed]
[27] Schreibelt, G., Klinkenberg, L.J., Cruz, L.J., Tacken, P.J., Tel, J., et al. (2012) The C-Type Lectin Receptor CLEC9A Mediates Antigen Uptake and (Cross-)presentation by Human Blood BDCA3+ Myeloid Dendritic Cells. Blood, 119, 2284-2292. [Google Scholar] [CrossRef] [PubMed]
[28] Piccioli, D., Tavarini, S., Borgogni, E., Steri, V., Nuti, S., et al. (2007) Functional Specialization of Human Circulating CD16 and CD1c Myeloid Dendritic-Cell Subsets. Blood, 109, 5371-5379. [Google Scholar] [CrossRef] [PubMed]
[29] Alculumbre, S. and Pattarini, L. (2016) Purification of Human Dendritic Cell Subsets from Peripheral Blood. Methods in Molecular Biology, 1423, 153-167. [Google Scholar] [CrossRef] [PubMed]
[30] Lindstedt, M., Lundberg, K. and Borrebaeck, C.A. (2005) Gene Family Clustering Identifies Functionally Associated Subsets of Human in Vivo Blood and Tonsillar Dendritic Cells. The Journal of Immunology, 175, 4839-4846. [Google Scholar] [CrossRef] [PubMed]
[31] Edwards, A.D., Diebold, S.S., Slack, E.M., Tomizawa, H., Hemmi, H., et al. (2003) Toll-Like Receptor Expression in Murine DC Subsets: Lack of TLR7 Expression by CD8 Alpha+ DC Correlates with Unresponsiveness to Imidazoquinolines. European Journal of Immunology, 33, 827-833. [Google Scholar] [CrossRef] [PubMed]
[32] Galibert, L., Diemer, G.S., Liu, Z., Johnson, R.S., Smith, J.L., et al. (2005) Nectin-Like Protein 2 Defines a Subset of T-Cell Zone Dendritic Cells and Is a Ligand for Class-I-Restricted T-Cell-Associated Molecule. The Journal of Biological Chemistry, 280, 21955-21964. [Google Scholar] [CrossRef] 
[33] Huysamen, C., Willment, J.A., Dennehy, K.M. and Brown, G.D. (2008) CLEC9A Is a Novel Activation C-Type Lectin-Like Receptor Expressed on BDCA3+ Dendritic Cells and a Subset of Monocytes. The Journal of Biological Chemistry, 283, 16693-16701. [Google Scholar] [CrossRef] 
[34] Sancho, D., Mourao-Sa, D., Joffre, O.P., Schulz, O., Rogers, N.C., et al. (2008) Tumor Therapy in Mice via Antigen Targeting to a Novel, DC-Restricted C-Type Lectin. Journal of Clinical Investigation, 118, 2098-2110. [Google Scholar] [CrossRef] 
[35] Poulin, L.F., Salio, M., Griessinger, E., Anjos-Afonso, F., Craciun, L., et al. (2010) Characterization of Human DNGR-1+ BDCA3+ Leukocytes as Putative Equivalents of Mouse CD8alpha+ Dendritic Cells. Journal of Experimental Medicine, 207, 1261-1271. [Google Scholar] [CrossRef] [PubMed]
[36] Hochrein, H., Shortman, K., Vremec, D., Scott, B., Hertzog, P., et al. (2001) Differential Production of IL-12, IFN-Alpha, and IFN-Gamma by Mouse Dendritic Cell Subsets. The Journal of Immunology, 166, 5448-5455. [Google Scholar] [CrossRef] [PubMed]
[37] Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F. and Lanzavecchia, A. (2001) Specialization and Complementarity in Microbial Molecule Recognition by Human Myeloid and Plasmacytoid Dendritic Cells. European Journal of Immunology, 31, 3388-3393. [Google Scholar] [CrossRef] 
[38] Segura, E., Touzot, M., Bohineust, A., Cappuccio, A., Chiocchia, G., et al. (2013) Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation. Immunity, 38, 336-348. [Google Scholar] [CrossRef] [PubMed]
[39] Siegal, F.P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P.A., Shah, K., et al. (1999) The Nature of the Principal Type 1 Inter-feron-Producing Cells in Human Blood. Science, 284, 1835-1837. [Google Scholar] [CrossRef] [PubMed]
[40] Cao, W., Rosen, D.B., Ito, T., Bover, L., Bao, M., et al. (2006) Plasmacytoid Dendritic Cell-Specific Receptor ILT7-Fc epsilonRI Gamma Inhibits Toll-Like Receptor-Induced Interferon Production. Journal of Experimental Medicine, 203, 1399-1405. [Google Scholar] [CrossRef] [PubMed]
[41] Di Pucchio, T., Chatterjee, B., Smed-Sorensen, A., Clayton, S., Palazzo, A., et al. (2008) Direct Proteasome-Independent Cross-Presentation of Viral Antigen by Plasmacytoid Dendritic Cells on Major Histocompatibility Complex Class I. Nature Immunology, 9, 551-557. [Google Scholar] [CrossRef] [PubMed]
[42] Fonteneau, J.F., Gilliet, M., Larsson, M., Dasilva, I., Munz, C., et al. (2003) Activation of Influenza Virus-Specific CD4+ and CD8+ T Cells: A New Role for Plasmacytoid Dendritic Cells in Adaptive Immunity. Blood, 101, 3520-3526. [Google Scholar] [CrossRef] [PubMed]
[43] Tel, J., Schreibelt, G., Sittig, S.P., Mathan, T.S., Buschow, S.I., et al. (2013) Human Plasmacytoid Dendritic Cells Efficiently Cross-Present Exogenous Ags to CD8+ T Cells Despite Lower Ag Uptake than Myeloid Dendritic Cell Subsets. Blood, 121, 459-467. [Google Scholar] [CrossRef] [PubMed]
[44] Banchereau, J., Thompson-Snipes, L., Zurawski, S., Blanck, J.P., Cao, Y., et al. (2012) The Differential Production of Cytokines by Human Langerhans Cells and Dermal CD14(+) DCs Controls CTL Priming. Blood, 119, 5742-5749. [Google Scholar] [CrossRef] [PubMed]
[45] Klechevsky, E., Morita, R., Liu, M., Cao, Y., Coquery, S., et al. (2008) Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic Cells. Im-munity, 29, 497-510. [Google Scholar] [CrossRef] [PubMed]
[46] Leon, B., Lopez-Bravo, M. and Ardavin, C. (2007) Mono-cyte-Derived Dendritic Cells Formed at the Infection Site Control the Induction of Protective T Helper 1 Responses against Leishmania. Immunity, 26, 519-531. [Google Scholar] [CrossRef] [PubMed]
[47] Zou, W. and Restifo, N.P. (2010) T(H)17 Cells in Tumour Immunity and Immunotherapy. Nature Reviews Immunology, 10, 248-256. [Google Scholar] [CrossRef] [PubMed]
[48] Muranski, P. and Restifo, N.P. (2009) Does IL-17 Promote Tumor Growth? Blood, 114, 231-232. [Google Scholar] [CrossRef] [PubMed]
[49] Munn, D.H. (2009) Th17 Cells in Ovarian Cancer. Blood, 114, 1134-1135. [Google Scholar] [CrossRef] [PubMed]
[50] Bronte, V. (2008) Th17 and Cancer: Friends or Foes? Blood, 112, 214. [Google Scholar] [CrossRef] [PubMed]

为你推荐